DASH vs PTCT · P/E 76, rev $13.72B vs rev $806.8M
DoorDash, Inc. Class A Common Stock (DASH) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the DASH and PTCT stock pages for the full models.
Not investment advice.